SupplierRadar

Liptis Pharmaceuticals Cigalah T

FDA import alert and refusal historyJeddah, Saudi ArabiaFEI 3014693171

Recorded by FDA as LIPTIS PHARMACEUTICALS CIGALAH T

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Liptis Pharmaceuticals Cigalah T.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectLiptis Pharmaceuticals Cigalah added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

As of October 26, 2026, Liptis Pharmaceuticals Cigalah T is not on any FDA import alert in SupplierRadar's records; FDA refused 1 of its shipment line on October 4, 2018, most often for unapproved new drug (UNAPPROVED).

Data from FDA public records, last checked . Request a correction

Current status

Import alerts
Not listed
Last import refusal
Ginkgo biloba (herbal & botanicals, not teas) · UNAPPROVED
Last warning letter
None found
Last inspection
None on record

Every FDA record for Liptis Pharmaceuticals Cigalah T

1 record, newest first. Each line links to the FDA page it came from.

2018

  1. Import refusal
    Refused, Ginkgo biloba (herbal & botanicals, not teas)UNAPPROVEDEntry AEK-5184195-2
    Source

Refusal charges, in plain English

  • UNAPPROVED1 refused line

    Unapproved new drug

    The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Liptis Pharmaceuticals Cigalah T

Is Liptis Pharmaceuticals Cigalah T on an FDA import alert?
No listing for Liptis Pharmaceuticals Cigalah T appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Saudi Arabia page.
Has FDA refused shipments from Liptis Pharmaceuticals Cigalah T?
Yes. FDA refused 1 shipment line from Liptis Pharmaceuticals Cigalah T on October 4, 2018. The most recent, on October 4, 2018, was ginkgo biloba (herbal & botanicals, not teas), charged as UNAPPROVED (unapproved new drug).
Why did FDA refuse Liptis Pharmaceuticals Cigalah T's shipments?
The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).
What is Liptis Pharmaceuticals Cigalah T's FEI number?
Liptis Pharmaceuticals Cigalah T's FDA Establishment Identifier (FEI) is 3014693171.

Buying from Liptis Pharmaceuticals Cigalah T?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Liptis Pharmaceuticals Cigalah T.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectLiptis Pharmaceuticals Cigalah added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.